Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Mersana Therapeutics Inc (NQ: MRSN ) 2.020 -0.020 (-0.98%) Streaming Delayed Price Updated: 4:00 PM EDT, Oct 3, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Mersana Therapeutics Inc < Previous 1 2 3 4 5 Next > MRSN Stock Earnings: Mersana Therapeutics Misses EPS, Misses Revenue for Q2 2024 August 13, 2024 MRSN stock results show that Mersana Therapeutics missed analyst estimates for earnings per share and missed on revenue for the second quarter of 2024. Via InvestorPlace MRSN Stock Earnings: Mersana Therapeutics Beats EPS, Beats Revenue for Q1 2024 May 09, 2024 MRSN stock results show that Mersana Therapeutics beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024. Via InvestorPlace Why Teledyne Technologies Shares Are Trading Lower By 9%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session April 24, 2024 Via Benzinga The Analyst Verdict: Mersana Therapeutics In The Eyes Of 5 Experts March 19, 2024 Via Benzinga Expert Outlook: Mersana Therapeutics Through The Eyes Of 5 Analysts February 29, 2024 Via Benzinga A Preview Of Mersana Therapeutics's Earnings February 27, 2024 Via Benzinga What To Know About Citigroup's Upgrade of Mersana Therapeutics December 04, 2023 Via Benzinga 12 Health Care Stocks Moving In Friday's After-Market Session March 15, 2024 Via Benzinga Why Butterfly Network Shares Are Trading Lower By 22%? Here Are Other Stocks Moving In Thursday's Mid-Day Session February 29, 2024 Shares of Butterfly Network, Inc. (NASDAQ: BFLY) fell sharply during Thursday’s session after the company reported mixed fourth-quarter financial results. Via Benzinga A Preview Of Mersana Therapeutics's Earnings November 06, 2023 Via Benzinga Why Mersana Therapeutics Stock Is Plunging Today? July 27, 2023 Mersana Therapeutics Inc (NASDAQ: MRSN) shares are sinking after the company announced that the UPLIFT clinical trial of upifitamab rilsodotin (UpRi) did Via Benzinga Hormel Foods Reports Upbeat Earnings, Joins Pure Storage, Okta, Papa John's International And Other Big Stocks Moving Higher On Thursday February 29, 2024 U.S. stocks were higher, with the Nasdaq Composite gaining around 50 points on Thursday. Via Benzinga Topics Stocks Exposures US Equities 3 Biotech Stocks to Turn $10,000 Into $1 Million: January 2024 January 22, 2024 Biotech stocks are some of the most exciting opportunities on the market. Find the right ones with catalysts, and you could make a fortune. Via InvestorPlace Elli Lilly Joins Big Pharma’s Multi-Billion-Dollar Oncology Race October 10, 2023 Large pharmaceutical companies are increasingly investing in cancer treatment stocks, driven by the promise of medical breakthroughs and financial rewards. Eli Lilly became the latest Big Pharma giant... Via PressReach What 4 Analyst Ratings Have To Say About Mersana Therapeutics June 16, 2023 Via Benzinga Why KeyCorp Shares Are Trading Lower By Over 5%? Here Are Other Stocks Moving In Thursday's Mid-Day Session January 18, 2024 Shares of KeyCorp (NYSE: KEY) moved lower during Thursday’s session after the company reported fourth-quarter financial results. Revenues of $1.538 billion, down 19.0% Y/Y, slightly topped the... Via Benzinga How To Invest In The Healthcare Sector August 19, 2023 If things go wrong with some healthcare companies, investors often justify why they stay in the stock. And when things go right, they can go right in a hurry. Mersana Therapeutics is an example of how... Via Talk Markets Dow Dips Over 200 Points; McDonald's Tops Q2 Expectations July 27, 2023 U.S. stocks turned lower toward the end of trading on Thursday, with the Dow Jones falling more than 200 points . The Dow traded down 0.59% to 35,310.03 while the NASDAQ fell 0.44% to 14,064.61. The... Via Benzinga Why Avantor Shares Are Trading Lower By 10%? Here Are Other Stocks Moving In Friday's Mid-Day Session July 28, 2023 Gainers Unique Fabricating, Inc. (NYSE: UFAB) shares jumped 113% to $0.4605 after gaining 12% on Thursday. Via Benzinga 12 Health Care Stocks Moving In Thursday's Intraday Session July 27, 2023 Via Benzinga Stocks That Hit 52-Week Lows On Thursday July 27, 2023 During Thursday, 56 stocks hit new 52-week lows. Via Benzinga Benzinga's Top Ratings Upgrades, Downgrades For July 28, 2023 July 28, 2023 Via Benzinga Nasdaq Up 1%; Meta Shares Surge Following Upbeat Results July 27, 2023 U.S. stocks traded higher midway through trading, with the Nasdaq Composite gaining around 1% on Thursday. Following the market opening Thursday, the Dow traded up 0.15% to 35,573.49 while the NASDAQ... Via Benzinga Dow Jumps 100 Points; US GDP Rises 2.4% In Q2 July 27, 2023 U.S. stocks traded higher this morning, following the release of major economic reports on Thursday. Following the market opening Thursday, the Dow traded up 0.28% to 35,620.79 while the NASDAQ rose... Via Benzinga Why Willis Towers Watson Shares Are Trading Lower By 9%? Here Are Other Stocks Moving In Thursday's Mid-Day Session July 27, 2023 Gainers Femasys Inc. (NASDAQ: FEMY) gained 54% to $0.55. Femasys reported a notice of allowance for new U.S. patent application covering use of FemBloc for female permanent birth control. Via Benzinga 12 Health Care Stocks Moving In Thursday's Pre-Market Session July 27, 2023 Via Benzinga Benzinga's Top Ratings Upgrades, Downgrades For July 27, 2023 July 27, 2023 Via Benzinga Cancer Drug Trials Put On Hold After Patients Died June 17, 2023 Recent reports from two drug companies that had been conducing separate clinical trials to evaluate cancer treatments reveal that the trials were halted due to the deaths of six participants, including... Via Benzinga Benzinga's Top Ratings Upgrades, Downgrades For June 16, 2023 June 16, 2023 Via Benzinga NVIDIA To Rally Over 17%? Here Are 10 Other Analyst Forecasts For Friday June 16, 2023 Raymond James boosted the price target for Jabil Inc. (NYSE: JBL) from $100 to $120. Raymond James analyst Melissa Fairbanks maintained a Strong Buy rating. Jabil shares rose 5% to close at $104.64 on... Via Benzinga < Previous 1 2 3 4 5 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
